Open AccessGenetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B
Author(s) -
Umaporn Limothai,
Natthaya Chuaypen,
Kittiyod Poovorawan,
Yong Poovorawan,
Pisit Tangkijvanich
Publication year - 2019
Publication title -
asian pacific journal of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 33
ISSN - 0125-877X
DOI - 10.12932/ap-020419-0533
Subject(s) - hbsag , pegylated interferon , hbeag , medicine , genotype , gastroenterology , single nucleotide polymorphism , hepatitis b virus , immunology , chronic hepatitis , virology , virus , biology , gene , biochemistry , ribavirin
Signaling pathways in the STAT4 gene play an essential role in interferon-mediated antiviral effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom